| Literature DB >> 15255932 |
Yuichi Hashimoto1, Yuka Kaneko, Emi Tsukamoto, Harald Frankowski, Keisuke Kouyama, Yoshiko Kita, Takako Niikura, Sadakazu Aiso, Dale E Bredesen, Masaaki Matsuoka, Ikuo Nishimoto.
Abstract
One of the most important pathological features of Alzheimer's disease (AD) is extracellular senile plaques, whose major component is amyloid-beta peptides (Abeta). Abeta binds to the extracellular domain of p75NTR (p75 neurotrophin receptor) and induces neuronal cell death. We investigated the molecular mechanism of Abeta-induced neurotoxicity in detail from the standpoint of interaction between p75NTR and its recently identified relative, PLAIDD (p75-like apoptosis-inducing death domain). Using F11 neuronal hybrid cells, we demonstrate that there are two distinct pathways for Abeta-induced toxicity mediated by p75NTR. One pathway that has been previously elucidated, is mediated by p75NTR, Go, JNK, NADPH oxidase and caspase3-related caspases. We found that PLAIDD and Gi proteins, heterotrimeric G proteins, are involved in the alternative Abeta-induced neurotoxicity mediated by p75NTR. The alternative pathway triggered by Abeta is thus mediated by p75NTR, PLAIDD, Gi, JNK, NADPH oxidase and caspase3-related caspases. In addition, we found that HN, ADNF, IGF-I, or bFGF inhibits both pathways of Abeta-induced neurotoxicity mediated by p75NTR.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15255932 DOI: 10.1111/j.1471-4159.2004.02513.x
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372